Article
Interleukin-17 gene polymorphisms contribute to cancer risk.
Mediators of inflammation - 1 Jan 2014
Niu Yu-Ming, Yuan Hua, Zhou Yu
Abstract excerpt
Epidemiological studies have suggested that interleukin-17 (IL-17) polymorphisms are associated with cancer risk. However, the results of these studies are inconsistent. Therefore, we performed a meta-analysis to obtain a precise conclusion. Odds ratios (ORs) with 95% confidence intervals (CIs) were used to assess the association of the IL-17A rs2275913G>A and IL-17F rs763780T>C polymorphisms with cancer risk....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
